Csx charting, page-101

I agree Veritas - although I don’t thing an announcement is forthcoming.

It’s a tightly held register and large internal shareholders have their vesting period (partial) ending Q1 FY22 from memory. I can’t imagine a sub IPO price for too much longer, although it may dip more In the near term on low volume.

I have been monitoring recent media reports (only source of company info thus far since the most recent announcement) where the CEO has indicated sales etc. as positive however that is all rhetoric until proven otherwise by an additional announcement or their half yearly. All macro factors indicate a positive climate for the business from a medical perspective, and industrials as we know are tracking as indicated.

Let’s see